<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>1322</number>
    <updateDate>2023-01-11T13:24:24Z</updateDate>
    <updateDateIncludingText>2023-01-11T13:24:24Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <originChamberCode>S</originChamberCode>
    <type>S</type>
    <introducedDate>2013-07-18</introducedDate>
    <congress>113</congress>
    <committees>
      <item>
        <systemCode>scnc00</systemCode>
        <name>United States Senate Caucus on International Narcotics Control</name>
        <chamber>Senate</chamber>
        <type>Other</type>
        <activities>
          <item>
            <name>Hearings by</name>
            <date>2014-05-14T18:30:00Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>ssju00</systemCode>
        <name>Judiciary Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2013-07-18T18:57:25Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>SALTS Act</title>
        <congress>113</congress>
        <number>4975</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2014-07-21</actionDate>
          <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2014-05-14</actionDate>
        <committees>
          <item>
            <systemCode>scnc00</systemCode>
            <name>United States Senate Caucus on International Narcotics Control</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Committee on United States Senate Caucus on International Narcotics Control. Hearings held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2013-09-25</actionDate>
        <committees>
          <item>
            <systemCode>scnc00</systemCode>
            <name>United States Senate Caucus on International Narcotics Control</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Committee on United States Senate Caucus on International Narcotics Control. Hearings held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2013-07-18</actionDate>
        <committees>
          <item>
            <systemCode>ssju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on the Judiciary.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2013-07-18</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>K000367</bioguideId>
        <fullName>Sen. Klobuchar, Amy [D-MN]</fullName>
        <firstName>Amy</firstName>
        <lastName>Klobuchar</lastName>
        <party>D</party>
        <state>MN</state>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>G000359</bioguideId>
        <fullName>Sen. Graham, Lindsey [R-SC]</fullName>
        <firstName>Lindsey</firstName>
        <lastName>Graham</lastName>
        <party>R</party>
        <state>SC</state>
        <sponsorshipDate>2013-07-18</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>F000062</bioguideId>
        <fullName>Sen. Feinstein, Dianne [D-CA]</fullName>
        <firstName>Dianne</firstName>
        <lastName>Feinstein</lastName>
        <party>D</party>
        <state>CA</state>
        <sponsorshipDate>2013-07-18</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>S000148</bioguideId>
        <fullName>Sen. Schumer, Charles E. [D-NY]</fullName>
        <firstName>Charles</firstName>
        <lastName>Schumer</lastName>
        <party>D</party>
        <state>NY</state>
        <middleName>E.</middleName>
        <sponsorshipDate>2013-09-12</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>W000802</bioguideId>
        <fullName>Sen. Whitehouse, Sheldon [D-RI]</fullName>
        <firstName>Sheldon</firstName>
        <lastName>Whitehouse</lastName>
        <party>D</party>
        <state>RI</state>
        <sponsorshipDate>2013-12-19</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B001265</bioguideId>
        <fullName>Sen. Begich, Mark [D-AK]</fullName>
        <firstName>Mark</firstName>
        <lastName>Begich</lastName>
        <party>D</party>
        <state>AK</state>
        <sponsorshipDate>2014-02-27</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Crime and Law Enforcement</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Drug trafficking and controlled substances</name>
        </item>
        <item>
          <name>Drug, alcohol, tobacco use</name>
        </item>
        <item>
          <name>Marketing and advertising</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Crime and Law Enforcement</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2013-07-18</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2013-11-12T21:30:50Z</updateDate>
        <text><![CDATA[ <p>Synthetic Abuse and Labeling of Toxic Substances Act of 2013 or the SALTS Act - Amends the Controlled Substances Act to provide that, in determining whether a controlled substance analogue was intended for human consumption, the following factors may be considered: (1) the marketing, advertising, and labeling of the substance; (2) the known efficacy or usefulness of the substance for the marketed, advertised, or labeled purpose; (3) the difference between the price at which the substance is sold and the price at which the substance it is purported to be or advertised as is normally sold; (4) the diversion of the substance from legitimate channels and the clandestine importation, manufacture, or distribution of the substance; and (5) whether the defendant knew or should have known that the substance was intended to be consumed by injection, inhalation, ingestion, or any other immediate means.</p> <p>Declares that evidence that a substance was not marketed, advertised, or labeled for human consumption shall not by itself be sufficient to establish that the substance was not intended for human consumption.</p>]]></text>
      </summary>
    </summaries>
    <title>SALTS Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>SALTS Act</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to amend the Controlled Substances Act relating to controlled substance analogues.</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>SALTS Act</title>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Synthetic Abuse and Labeling of Toxic Substances Act of 2013</title>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2013-07-18T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-113s1322is/xml/BILLS-113s1322is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2014-05-14</actionDate>
      <text>Committee on United States Senate Caucus on International Narcotics Control. Hearings held.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
